What are the differences in the management of hyperosmolar hyperglycemic state (HHS) and diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management Differences Between HHS and DKA

The primary difference in managing HHS versus DKA is that fluid resuscitation is the cornerstone of HHS treatment while insulin therapy is the cornerstone of DKA treatment, though both require aggressive fluid replacement, insulin, and electrolyte monitoring. 1

Key Diagnostic Thresholds

DKA criteria:

  • Glucose ≥250 mg/dL
  • pH <7.3
  • Bicarbonate <15 mEq/L
  • Moderate ketonuria/ketonemia 2

HHS criteria:

  • Glucose ≥600 mg/dL (some guidelines use ≥30-33.3 mmol/L)
  • pH ≥7.3
  • Bicarbonate ≥15 mEq/L
  • Altered mental status or severe dehydration
  • Osmolality ≥320 mOsm/kg 2, 3

Fluid Management: The Critical Difference

HHS Approach

  • More aggressive fluid replacement is essential - HHS patients have more profound dehydration (typically 8-10L deficit vs 3-6L in DKA)
  • Replace approximately 50% of estimated fluid loss within first 12 hours 3
  • Initial rate: 15-20 mL/kg/h or 1-1.5 L/h of 0.9% normal saline 3
  • Target osmolality correction: <3 mOsm/kg/h (some UK guidelines accept 3-8 mOsm/kg/h) 3
  • Fluid replacement takes priority over insulin in HHS 1

DKA Approach

  • Standard fluid resuscitation at typical rates
  • Fluid is important but insulin therapy is the primary treatment focus 1

Insulin Therapy: Dosing Differences

DKA

  • Continuous IV insulin infusion preferred for moderate-to-severe cases 4, 2
  • Standard rate: 0.1 units/kg/h 2
  • Mild DKA can use subcutaneous insulin with priming dose of 0.4-0.6 units/kg (half IV bolus, half SC/IM), then 0.1 unit/kg SC/IM hourly 2
  • Target glucose decline: 50-75 mg/dL/h 2

HHS

  • Lower insulin infusion rate: 0.05 units/kg/h, increasing by 1 unit/h as needed 3
  • When glucose reaches 300 mg/dL in HHS (vs 250 mg/dL in DKA), start insulin infusion 2
  • Insulin is secondary to fluid resuscitation in treatment priority 1

Monitoring Differences

DKA-Specific

  • Monitor ketones directly - β-hydroxybutyrate is preferred over nitroprusside method 2
  • Ketonemia takes longer to clear than hyperglycemia 2
  • Follow venous pH and anion gap every 2-4 hours 2

HHS-Specific

  • Monitor osmolality closely - primary marker of treatment response
  • Mental status changes correlate with osmolality
  • Less frequent need for pH/ketone monitoring

Resolution Criteria

DKA Resolution

  • Glucose <200 mg/dL
  • Bicarbonate ≥18 mEq/L
  • Venous pH >7.3 2

HHS Resolution

  • Osmolality normalized
  • Mental status improved
  • Adequate hydration restored

Critical Pitfalls

Hypokalaemia occurs in ~50% during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality - monitor potassium every 2-4 hours in both conditions 4

In adults with mixed DKA/HHS features (occurs in up to one-third of cases):

  • Administer fluids more rapidly than in pure DKA
  • Risk of fatal cerebral edema is low in adults
  • Undertreatment causes vascular occlusion and increased mortality 1, 5

In pediatric patients with mixed features:

  • Avoid rapid correction to prevent cerebral edema
  • Do NOT give initial insulin bolus 2
  • Use more conservative fluid rates (1.5× maintenance, not exceeding 2× maintenance) 2

Transition to Subcutaneous Insulin

Continue IV insulin 1-2 hours after starting subcutaneous regimen to prevent rebound hyperglycemia - abrupt discontinuation leads to poor control 2

Mortality rates differ significantly: HHS mortality is 5-16% (10× higher than DKA which is <1%), making aggressive early management even more critical 6

Related Questions

How should I manage a diabetic patient with an insulin pump who presents with diabetic ketoacidosis or hyperosmolar hyperglycemic state?
Is bowel rest (nil by mouth) a standard component of management for a hyperglycemic crisis such as diabetic ketoacidosis or hyperosmolar hyperglycemic state?
Can severe hyperglycemia, such as in hyperosmolar hyperglycemic state or diabetic ketoacidosis, precipitate seizures?
In a diabetic patient non‑adherent to therapy with a blood glucose of 500 mg/dL but without diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), how should this episode be classified and why does it require hospital admission?
What is the difference between Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) in terms of diagnosis and treatment?
What are the minimum age and weight requirements for using diclofenac and ketorolac injections for pain management?
What is the best position for a patient with persistent vomiting?
How should a clinical trial be designed to compare early video‑assisted thoracoscopic surgery versus conventional tube thoracostomy (and intrapleural fibrinolytic therapy) in adult patients with confirmed thoracic empyema, including appropriate inclusion and exclusion criteria, interventions, and outcome measures?
Does glucocorticoid replacement therapy for Addison disease lead to poor peripheral venous access over time?
What is the recommended continuous intravenous infusion dose of midazolam for adults and pediatric patients?
Is the rate of fluid correction slower in hyperosmolar hyperglycemic state (HHS) than in diabetic ketoacidosis (DKA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.